{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:08:26Z","timestamp":1773659306398,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,7,9]],"date-time":"2007-07-09T00:00:00Z","timestamp":1183939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s11936-007-0024-3","type":"journal-article","created":{"date-parts":[[2007,7,16]],"date-time":"2007-07-16T22:58:49Z","timestamp":1184626729000},"page":"289-301","source":"Crossref","is-referenced-by-count":21,"title":["Heart failure and cardiac hypertrophy"],"prefix":"10.1007","volume":"9","author":[{"given":"J. Eduardo","family":"Rame","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel L.","family":"Dries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,7,9]]},"reference":[{"key":"24_CR1","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1073\/pnas.79.10.3310","volume":"79","author":"J.M. Pfeffer","year":"1982","unstructured":"Pfeffer JM, Pfeffer MA, Mirsky I, et al.: Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. Proc Natl Acad Sci U S A 1982, 79:3310\u20133314.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"24_CR2","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1161\/01.CIR.91.10.2642","volume":"91","author":"S.E. Litwin","year":"1995","unstructured":"Litwin SE, Katz SE, Weinberg EO, et al.: Serial echocardiographic Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Circulation 1995, 91:2642\u20132654.","journal-title":"Circulation"},{"key":"24_CR3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","volume":"93","author":"J.D. Molkentin","year":"1998","unstructured":"Molkentin JD, Lu JR, Antos CL, et al.: A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998, 93:215\u2013228.","journal-title":"Cell"},{"key":"24_CR4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.amjcard.2003.09.050","volume":"93","author":"J.E. Rame","year":"2004","unstructured":"Rame JE, Ramilo M, Spencer N, et al.: Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fraction. Am J Cardiol 2004, 93:234\u2013237.","journal-title":"Am J Cardiol"},{"key":"24_CR5","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.jacc.2003.11.064","volume":"43","author":"M.H. Drazner","year":"2004","unstructured":"Drazner MH, Rame JE, Marino EK, et al.: Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection within five years. The Cardiovascular Health Study. J Am Coll Cardiol 2004, 43:2207\u20132215.","journal-title":"J Am Coll Cardiol"},{"key":"24_CR6","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jacc.2003.11.040","volume":"43","author":"M. Klapholz","year":"2004","unstructured":"Klapholz M, Maurer M, Lowe AM, et al.: Hospitalization for Heart Failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol 2004, 43:1432\u20131438.","journal-title":"J Am Coll Cardiol"},{"key":"24_CR7","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0735-1097(99)00118-7","volume":"33","author":"R. Vasan","year":"1999","unstructured":"Vasan R, Larson MG, Benjamin EJ, et al.: Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999, 33:1948\u20131955.","journal-title":"J Am Coll Cardiol"},{"key":"24_CR8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM198501313120504","volume":"312","author":"E.J. Topol","year":"1985","unstructured":"Topol EJ, Traill TA, Fortuin NJ, et al.: Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med 1985, 312:277\u2013283.","journal-title":"N Engl J Med"},{"key":"24_CR9","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/01.CIR.90.4.1786","volume":"90","author":"D. Levy","year":"1994","unstructured":"Levy D, Salomon M, Agostino RB, et al.: Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994, 90:1786\u20131793.","journal-title":"Circulation"},{"key":"24_CR10","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/00004872-199510000-00003","volume":"13","author":"M.L. Muiesan","year":"1995","unstructured":"Muiesan ML, Salvett M, Rizzoni D, et al.: Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens 1995, 13:1091\u20131105.","journal-title":"J Hypertens"},{"key":"24_CR11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.97.1.48","volume":"97","author":"P. Verdecchia","year":"1998","unstructured":"Verdecchia P, Schillaci G, Borgioni C, et al.: Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998, 97:48\u201354.","journal-title":"Circulation"},{"key":"24_CR12","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/hc3901.096700","volume":"104","author":"J. Mathew","year":"2001","unstructured":"Mathew J, Sleight P, Lonn E, et al.: Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 2001, 104:1615\u20131621.","journal-title":"Circulation"},{"key":"24_CR13","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/0735-1097(95)00606-0","volume":"27","author":"M. Moser","year":"1996","unstructured":"Moser M, Herbert PR: Prevention of disease progression. LVH and CHF in hypertension treatment trials. J Am Coll Cardiol 1996, 27:1214\u20131217.","journal-title":"J Am Coll Cardiol"},{"key":"24_CR14","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"A.V. Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, et al.: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003, 289:2560\u20132572.","journal-title":"JAMA"},{"key":"24_CR15","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","volume":"359","author":"B. Dahlof","year":"2002","unstructured":"Dahlof B, Devereux RB, Kjeldsen S, et al.: Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Lancet 2002, 359:995\u20131003.","journal-title":"Lancet"},{"key":"24_CR16","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/01.CIR.0000141573.44737.5A","volume":"110","author":"R.B. Devereux","year":"2004","unstructured":"Devereux RB, Dahlof B, Gerdts S, et al.: Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 2004, 110:1456\u20131462.","journal-title":"Circulation"},{"key":"24_CR17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0022-4804(03)00189-6","volume":"113","author":"G.F. Adami","year":"2003","unstructured":"Adami GF, Cordera R, Camerini G, et al.: Recovery of insulin sensitivity in obese patients at short term after biliopancreatic diversion. J Surg Res 2003, 113:217\u2013221.","journal-title":"J Surg Res"},{"key":"24_CR18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1381\/096089203322190844","volume":"13","author":"A. Molina","year":"2003","unstructured":"Molina A, Vendrell J, Gutierrez C: Insulin resistance, leptin and TNF-alpha system in morbidly obese women after gastric bypass. Obes Surg 2003, 13:615\u2013621.","journal-title":"Obes Surg"},{"key":"24_CR19","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/bmj.315.7113.912","volume":"315","author":"K. Karason","year":"1997","unstructured":"Karason K, Wallentin I, Larsson B, et al.: Effects of obesity and weight loss on left ventricular mass and relative wall thickness: survey and intervention study. BMJ 1997, 315:912\u2013916.","journal-title":"BMJ"},{"key":"24_CR20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/HJH.0b013e3280115bfb","volume":"25","author":"I. Ikonomidis","year":"2007","unstructured":"Ikonomidis I, Mazarakis A, Papadopoulos C, et al.: Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a three year follow-up study. J Hypertens 2007, 25:439\u2013447.","journal-title":"J Hypertens"},{"key":"24_CR21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ajh\/5.2.95","volume":"5","author":"B. Dahlof","year":"1992","unstructured":"Dahlof B, Pennert K, Hansson L, et al.: Reversal of left ventricular hypertrophy in hypertensive patients: a meta-analysis of 109 treatment studies. Am J Hypertens 1992, 5:95\u2013110.","journal-title":"Am J Hypertens"},{"key":"24_CR22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9343(03)00158-X","volume":"115","author":"A.U. Klingbeil","year":"2003","unstructured":"Klingbeil AU, Schneider M, Martus P, et al.: A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 2003, 115:41\u201346.","journal-title":"Am J Med"},{"key":"24_CR23","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.cardfail.2005.06.432","volume":"11","author":"P. Carson","year":"2005","unstructured":"Carson P, Massie BM, Mckelvie R, et al.: The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design. J Card Fail 2005, 11:576\u2013585.","journal-title":"J Card Fail"},{"key":"24_CR24","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","volume":"362","author":"S. Yusuf","year":"2003","unstructured":"Yusuf S, Pfeffer MA, Swedberg K, et al.: Effects of candesartan in patients with chronic heart failure and preserved left ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003, 362:777\u2013781.","journal-title":"Lancet"},{"key":"24_CR25","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","volume":"283","author":"A. Hjalmarson","year":"2000","unstructured":"Hjalmarson A, Goldstein S, Fagerberg B, et al.: Effects of controlled-release metoprolol on total mortality, hospitalizations, and well being in patients with heart failure: the Metoprolol CR\/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). JAMA 2000, 283:1295\u20131302.","journal-title":"JAMA"},{"key":"24_CR26","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B. Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003, 348:1309\u20131321.","journal-title":"N Engl J Med"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-007-0024-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-007-0024-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-007-0024-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:56:31Z","timestamp":1559422591000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-007-0024-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,9]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["24"],"URL":"https:\/\/doi.org\/10.1007\/s11936-007-0024-3","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,9]]}}}